FR940302-2-00062 FR940302-2-00043 Therefore, under section 505(e) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(e)) and under authority delegated to the Director of the Center for Drug Evaluation and Research (21 CFR 5.82), approval of the NDA's listed above, and all amendments and supplements thereto, is hereby withdrawn, effective April 1, 1994. Dated: February 3, 1994. Gerald F. Meyer, Acting Director, Center for Drug Evaluation and Research. [FR Doc. 94&hyph;4660 Filed 3&hyph;1&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;P
